Search results for "DOPAMINE"

showing 10 items of 660 documents

Is there evidence for a rostral-caudal gradient in fronto-striatal loops and what role does dopamine play?

2018

Research has shown that the lateral prefrontal cortex (LPFC) may be hierarchically organized along a rostral-caudal functional gradient such that control processing becomes progressively more abstract from caudal to rostral frontal regions. Here, we briefly review the most recent functional MRI, neuropsychological, and electrophysiological evidence in support of a hierarchical LPFC organization. We extend these observations by discussing how such a rostral-caudal gradient may also exist in the striatum and how the dopaminergic system may play an important role in the hierarchical organization of fronto-striatal loops. There is evidence indicating that a rostral-caudal gradient of dopamine r…

0301 basic medicinehierarchical processingReviewStriatumBiologylcsh:RC321-57103 medical and health sciences0302 clinical medicineDopaminemedicineHierarchical organizationlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryGeneral NeuroscienceDopaminergicNeuropsychologylateral prefrontal cortexElectrophysiology030104 developmental biologynervous systemDopamine receptorfronto-striatal loopsreceptor distributiondopamineLateral prefrontal cortexNeuroscience030217 neurology & neurosurgeryNeurosciencemedicine.drug
researchProduct

Acetaldehyde as the first hit of addictive behaviour

2016

Unhealthy alcohol use is common in the Western society, which puts risk of health consequences, causing multiple behavioural injuries. Increasing evidence focuses on acetaldehyde, the first metabolite of ethanol, as the mediator of the several behavioural actions of alcohol, including its rewarding and motivational effects. In particular, acetaldehyde induces dopamine release in the nucleus accumbens modulating primary alcohol rewarding effect, drug seeking, and relapse behaviour. Recent behavioural studies point at acetaldehyde as a drug of abuse since its oral self-administration is induced and maintained in an operant/conflict paradigm. These findings provide further evidence on the role…

0301 basic medicinemedicine.medical_specialtyAddictive behaviourmedia_common.quotation_subjectAlcohol abuseAlcoholAcetaldehydePlant SciencePharmacologyNucleus accumbensGeneral Biochemistry Genetics and Molecular BiologyEthanol-related effect03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMediatorDopamineEthanol-related effectsAcetaldehyde; Addictive behaviour; Ethanol-related effects; Biochemistry Genetics and Molecular Biology (all); Plant Science; Biochemistry (medical)medicinePsychiatrylcsh:QH301-705.5media_commonBiochemistry Genetics and Molecular Biology (all)EthanolAddictionBiochemistry (medical)Acetaldehydemedicine.disease030104 developmental biologylcsh:Biology (General)chemistryPsychology030217 neurology & neurosurgerymedicine.drugJournal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale
researchProduct

Pain-induced alterations in the dynorphinergic system within the mesocorticolimbic pathway: Implication for alcohol addiction.

2020

Latest studies have revealed that pain negatively impacts on reward processing and motivation leading to negative affective states and stress. These states not only reduce quality of life of patients by increasing the appearance of psychiatric comorbidities, but also have an important impact on vulnerability to drug abuse, including alcohol. In fact, clinical, epidemiological but also preclinical studies have revealed that the presence of pain is closely related to alcohol use disorders (AUDs). All this evidence suggests that pain is a factor that increases the risk of suffering AUD, predicting heavy drinking behavior and relapse drinking in those patients with a previous history of AUD. Th…

0301 basic medicinemedicine.medical_specialtyDopamineAlcohol use disorderMesolimbic pathwayκ-opioid receptor03 medical and health sciencesCellular and Molecular NeuroscienceReward system0302 clinical medicineQuality of lifeRewardmental disordersmedicineHumansPsychiatrybusiness.industryDopaminergicChronic painmedicine.diseaseSubstance abuseAlcoholism030104 developmental biologyQuality of LifeChronic Painbusiness030217 neurology & neurosurgeryJournal of neuroscience researchREFERENCES
researchProduct

Neurotransmitters and Behavioral Alterations Induced by Nickel Exposure.

2020

Background:: Nickel ions (Ni2+) are a heavy metal with wide industrial uses. Environmental and occupational exposures to Ni are potential risk factors for brain dysfunction and behavioral and neurological symptoms in humans. Methods: We reviewed the current evidence about neurochemical and behavioral alterations associated with Ni exposure in laboratory animals and humans. Results: Ni2+ exposure can alter (both inhibition and stimulation) dopamine release and inhibit glutamate NMDA receptors. Few reports claim an effect of Ni2+ at the level of GBA and serotonin neurotransmission. At behavioral levels, exposure to Ni2+ in rodents alters motor activity, learning and memory as well as anxiety…

0301 basic medicinemedicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationStimulationEnvironmental Illness03 medical and health scienceschemistry.chemical_compound0302 clinical medicineNeurochemicalDopamineNickelInternal medicineImmunology and AllergyMedicineAnimalsHumanseducationNeurotransmittereducation.field_of_studyBehaviorNeurotransmitter Agentsbusiness.industryMental DisordersGlutamate receptorEnvironmental Exposure030104 developmental biologyEndocrinologychemistryNMDA receptorSerotoninbusiness030217 neurology & neurosurgerymedicine.drugEndocrine, metabolicimmune disorders drug targets
researchProduct

A Stage-Based Approach to Therapy in Parkinson’s Disease

2019

Parkinson’s disease (PD) is a neurodegenerative disorder that features progressive, disabling motor symptoms, such as bradykinesia, rigidity, and resting tremor. Nevertheless, some non-motor symptoms, including depression, REM sleep behavior disorder, and olfactive impairment, are even earlier features of PD. At later stages, apathy, impulse control disorder, neuropsychiatric disturbances, and cognitive impairment can present, and they often become a heavy burden for both patients and caregivers. Indeed, PD increasingly compromises activities of daily life, even though a high variability in clinical presentation can be observed among people affected. Nowadays, symptomatic drugs and non-phar…

0301 basic medicinemedicine.medical_specialtyParkinson's diseaseImpulse control disorderlcsh:QR1-502ReviewDiseasel-dopaBiochemistryREM sleep behavior disorderMotor symptomslcsh:MicrobiologyAntiparkinson Agentsnon-pharmacological therapy03 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicineHumansdopamine-agonistsApathyanticholinergicsResting tremorMolecular Biologyamantadinebusiness.industryAmantadineParkinson Diseasemonoamine oxidase inhibitorsmotor symptomsmedicine.diseasenon-motor symptoms030104 developmental biologyacetylcholinesterase inhibitorsParkinson’s disease<span style="font-variant: small-caps">l</span>-dopaSettore MED/26 - Neurologiamedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugBiomolecules
researchProduct

Current disease modifying approaches to treat Parkinson's disease

2015

Parkinson's disease (PD is a progressive neurological disorder characterized by the degeneration and death of midbrain dopamine and non-dopamine neurons in the brain leading to motor dysfunctions and other symptoms, which seriously influence the quality of life of PD patients. The drug L-dopa can alleviate the motor symptoms in PD, but so far there are no rational therapies targeting the underlying neurodegenerative processes. Despite intensive research, the molecular mechanisms causing neuronal loss are not fully understood which has hampered the development of new drugs and disease-modifying therapies. Neurotrophic factors are by virtue of their survival promoting activities attract candi…

0301 basic medicinemedicine.medical_specialtyParkinson's diseaseNeurturinNeurotrophic factorBiologySettore BIO/09 - Fisiologia03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineNeuroinflammationDopamineNeurotrophic factorsInternal medicineα-SynucleinmedicineGlial cell line-derived neurotrophic factorMolecular BiologyCerebral dopamine neurotrophic factorDopamine neuronPharmacologyDopaminergicCell Biologymedicine.diseaseDopamine neurons; ER stress; Mitochondria; Neuroinflammation; Neuropeptides; Neurotrophic factors; Protein aggregation; α-Synuclein; Molecular Medicine; Molecular Biology; Pharmacology; Cellular and Molecular Neuroscience; Cell Biology3. Good healthMitochondriaNeuropeptide030104 developmental biologyNerve growth factorEndocrinologybiology.proteinER streMolecular MedicineProtein aggregationNeuroscience030217 neurology & neurosurgerymedicine.drug
researchProduct

2017

The mammalian retina harbors a circadian clockwork that regulates vision and promotes healthiness of retinal neurons, mainly through directing the rhythmic release of the neurohormones dopamine-acting on dopamine D4 receptors-and melatonin-acting on MT1 and MT2 receptors. The gene Gnaz-a unique Gi/o subfamily member-was seen in the present study to be expressed in photoreceptors where its protein product Gαz shows a daily rhythm in its subcellular localization. Apart from subcellular localization, Gnaz displays a daily rhythm in expression-with peak values at night-in preparations of the whole retina, microdissected photoreceptors and photoreceptor-related pinealocytes. In retina, Gnaz rhyt…

0301 basic medicinemedicine.medical_specialtyRetinaMultidisciplinarygenetic structuresG proteinDopaminergicBiologyeye diseasesPinealocyteCell biology03 medical and health sciencesPineal gland030104 developmental biology0302 clinical medicinemedicine.anatomical_structureEndocrinologyDopamineInternal medicinemedicinesense organsCircadian rhythmSignal transduction030217 neurology & neurosurgerymedicine.drugPLOS ONE
researchProduct

Glutamate and opioid antagonists modulate dopamine levels evoked by innately attractive male chemosignals in the nucleus accumbens of female rats

2017

Sexual chemosignals detected by vomeronasal and olfactory systems mediate intersexual attraction in rodents, and act as a natural reinforcer to them. The mesolimbic pathway processes natural rewards, and the nucleus accumbens receives olfactory information via glutamatergic projections from the amygdala. Thus, the aim of this study was to investigate the involvement of the mesolimbic pathway in the attraction toward sexual chemosignals. Our data show that female rats with no previous experience with males or their chemosignals display an innate preference for male-soiled bedding. Focal administration of the opioid antagonist b-funaltrexamine into the posterior ventral tegmental area does no…

0301 basic medicinemedicine.medical_specialtySexual attractionmedicine.drug_classSistema nerviós central MalaltiesNeuroscience (miscellaneous)olfactory systemMesolimbic pathwayNucleus accumbensAmygdalaNaltrexonePheromones03 medical and health sciencesCellular and Molecular NeuroscienceFeromones0302 clinical medicineNeurochemicalRewardDopamineInternal medicinemedicinerewardOriginal ResearchMesolimbic systemsexual attractionOlfactory systemVentral tegmental areaNeuroanatomy030104 developmental biologymedicine.anatomical_structureEndocrinologymesolimbic systemAnatomypheromonesPsychologyNeuroscience030217 neurology & neurosurgeryOpioid antagonistTecnologia farmacèuticamedicine.drug
researchProduct

Ocular Clocks: Adapting Mechanisms for Eye Functions and Health

2018

Vision is a highly rhythmic function adapted to the extensive changes in light intensity occurring over the 24-hour day. This adaptation relies on rhythms in cellular and molecular processes, which are orchestrated by a network of circadian clocks located within the retina and in the eye, synchronized to the day/night cycle and which, together, fine-tune detection and processing of light information over the 24-hour period and ensure retinal homeostasis. Systematic or high throughput studies revealed a series of genes rhythmically expressed in the retina, pointing at specific functions or pathways under circadian control. Conversely, knockout studies demonstrated that the circadian clock re…

0301 basic medicineretinavisiongenetic structuresPeriod (gene)[SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/NeurobiologyCircadian clockCLOCK ProteinsGene ExpressionContext (language use)melatoninReviewBiologyrhythm03 medical and health scienceschemistry.chemical_compoundCircadian ClocksmedicineAnimalsHumansCircadian rhythmOcular Physiological PhenomenaComputingMilieux_MISCELLANEOUSRetinaAdaptation OcularRetinalphotoreceptorCircadian RhythmCLOCKLight intensity030104 developmental biologymedicine.anatomical_structurecircadianchemistrysense organsdopamineNeuroscienceInvestigative Ophthalmology & Visual Science
researchProduct

Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys

2014

Objective Mounting evidence suggests that α-synuclein, a major protein component of Lewy bodies (LB), may be responsible for initiating and spreading the pathological process in Parkinson disease (PD). Supporting this concept, intracerebral inoculation of synthetic recombinant α-synuclein fibrils can trigger α-synuclein pathology in mice. However, it remains uncertain whether the pathogenic effects of recombinant synthetic α-synuclein may apply to PD-linked pathological α-synuclein and occur in species closer to humans. Methods Nigral LB-enriched fractions containing pathological α-synuclein were purified from postmortem PD brains by sucrose gradient fractionation and subsequently inoculate…

0303 health sciencesPathologymedicine.medical_specialtyLewy bodyanimal diseasesDopaminergicNeurodegenerationEndogenySubstantia nigraStriatumBiologymedicine.diseaseMacaquenervous system diseases03 medical and health sciences0302 clinical medicinenervous systemNeurologybiology.animalmedicineNeurology (clinical)030217 neurology & neurosurgeryIntracellular030304 developmental biologyAnnals of Neurology
researchProduct